The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global structural heart imaging market was valued at US$ 16.2 Billion in 2021.
We expect the global structural heart imaging market to exhibit a CAGR of 10.60% during 2022-2027.
The rising prevalence of cardiac diseases, coupled with the extensive application of structural heart
imaging process for diagnosing various heart conditions with high precision and resolution
cameras, is primarily driving the global structural heart imaging market.
The sudden outbreak of the COVID-19 pandemic has led to the growing demand for structural heart
imaging as the COVID-19 infection affects the cardiovascular system by increasing the risk of heart
failure in patients with pre-existing cardiac conditions.
Based on the imaging modality, the global structural heart imaging market can be bifurcated into
echocardiogram and angiogram. Currently, echocardiogram accounts for the majority of the total
On a regional level, the market has been classified into North America, Europe, Asia-Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global structural heart imaging market include Abbott Laboratories,
Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Edwards Lifesciences Corporation,
Integer Holdings Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd.,
LivaNova PLC, Medtronic plc, Pie Medical Imaging B.V., and Siemens Healthcare GmbH.
Home Healthcare Market by Product (Therapeutic Products, Testing, Screening, and Monitoring Products, Mobility Care Products), Service (Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, Pregnancy Care), Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases & Hypertension, Pregnancy, Wound Care, Diabetes, Hearing Disorders, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at